Antiretroviral Current Events | Antiretroviral News | 2
|
| Page
2 of
8 |
156 Results |
|
|
|
Sort By:
Page Views | Date |
Study finds limited options for backup HIV treatment in some developing countries
Thai researchers have discovered that patients who fail treatment with a commonly used, inexpensive, first-line antiretroviral therapy (ART) are also usually resistant to other, similar drugs, leaving progressively fewer options for replacement therapies. view more (2007-01-09)
Study finds limited options for backup HIV treatment in some developing countries
Thai researchers have discovered that patients who fail treatment with a commonly used, inexpensive, first-line antiretroviral therapy (ART) are also usually resistant to other, similar drugs, leaving progressively fewer options for replacement therapies. view more (2007-01-09)
Breastfeeding now safer for infants of HIV-infected mothers
An antiretroviral drug already in widespread use in the developing world to prevent the transmission of HIV from infected mothers to their newborns during childbirth has also been found to substantially cut the risk of subsequent HIV transmission during breast-feeding. view more (2008-02-05)
New Approaches To HIV Treatment In Less-developed Countries (pp 404, 410)
Two Viewpoint articles in this week's issue of THE LANCET highlight how the use of highly-active antiretroviral therapy (HAART) for HIV-1 treatment - currently only widely available in industrialised countries - could become accessible in less-developed settings. Both articles suggest new strategies for implementing HAART using infrastructure... view more... (2001-08-01)
To slow AIDS in Russia, treat HIV-positive addicts, Stanford study says
The key to combating AIDS in Russia may be to treat HIV-infected drug users. A new model estimating the spread of HIV in Russia suggests that treating injection drug users with antiretroviral medication will slow transmission of the virus among the general population. view more (2006-11-10)
World aides series : advances in research in prevention of mother-to-child HIV-1 transmission
'Although substantial progress has been made in preventing mother-to-child HIV-1 transmission in the past decade, critical research questions remain. Two perinatal epidemics now exist. In more-developed countries, integration of prenatal HIV-1 counselling and testing programmes into an existing antenatal infrastructure, availability of effective... view more... (2000-06-22)
Aids : Effectiveness of antiretroviral therapy demonstrated in Africa
Tritherapies using antiretroviral drugs have proved their worth in industrialized countries in the fight against Aids. However, in Sub-Saharan Africa, where 70 % of people infected with HIV live, access to such treatments is extremely limited. High cost, complicated procedures, combined with inadequate infrastructures for following up patients or... view more... (2002-06-27)
Important factors in compliance with HIV regimens identified; and more
Adherence to HIV medications is the greatest predictor of death. How well patients with HIV adhere to their regimens of highly active antiretroviral therapy (HAART) medication depends on a variety of factors, either positive or negative, many of which are common to patients around the world. view more (2006-11-21)
HIV integrase inhibitor effective for patients beginning antiretroviral treatment
A member of a new class of antiretroviral drugs is safe and effective for patients beginning treatment against HIV, according to researchers who have completed a two-year multisite phase III clinical trial comparing it with standard antiretroviral drugs. view more (2009-08-03)
South African Government Urged To Take Action In Preventing Mother-To-Child HIV Transmission (p 992)
Leading South African scientists, writing in a Commentary in this week's issue of THE LANCET, are calling on their government to implement antiretroviral drug programmes without delay to reduce the vertical transmission of HIV-1 infection from pregnant women to their children. Around 75,000 South African children were born with HIV-1 infection in... view more... (2002-03-20)
Anti-HIV Therapy Boosts Life Expectancy
The life expectancy for patients with human immunodeficiency virus (HIV) has increased by more than 13 years since the late 1990s thanks to advancements in antiretroviral therapy, according to researchers at the University of Alabama at Birmingham (UAB) and Simon Fraser University in Vancouver, British Columbia. view more (2008-07-28)
OHSU researchers discover possible HIV therapy in an animal study
Researchers have published a new study this week suggesting an important component of the immune system damaged by AIDS can possibly be replaced. view more (2006-06-09)
Study Suggests Potential Of Low-cost Options For Monitoring Disease Status In Hiv-1-Infected Children In Less-developed Countries (pp 1597, 1625)
Authors of a research letter in this week's issue of THE LANCET highlight how assessment of total blood lymphocyte count and albumen concentrations could have potential as low-cost alternatives in assessing the disease status of HIV-1-infected children in less-developed countries. The cost of laboratory analysis of CD4 lymphocyte count and... view more... (2003-11-12)
Resistance to anti-HIV drugs in Uganda developed due to drug supply problems
Some HIV-infected patients in Uganda who self-paid for their antiretroviral medications experienced interruptions in drug supply due to either financial demands or supply logistical disruptions. view more (2007-04-23)
Timely Antiretroviral Therapy Essential For Best Prognosis In People With HIV-1 Infection (p 119)
Authors of an international study in this week's issue of THE LANCET highlight how timely treatment with highly-active antiretroviral therapy (HAART) can substantially improve the three-year prognosis for people with HIV-1 infection. HAART became widespread in more-developed countries in 1996. However, there is insufficient data from individual... view more... (2002-07-10)
Antiretroviral Therapy Around Childbirth Reduces Risk Of Mother-To-Child HIV-1 Transmission (pp 1168, 1178)
Antiretroviral therapy given to women before, during, and after childbirth could be beneficial in reducing mother-to-child HIV-1 transmission in the first few weeks after delivery, suggest authors of a study in this week's issue of THE LANCET. However, this short-term benefit could be compromised unless new interventions are identified to prevent... view more... (2002-04-04)
New treatment model for HIV
Treatment of HIV patients must balance the need to suppress viral replication against the harmful side effects and significant cost to the patient of antiretroviral therapy. view more (2007-07-13)
FEMALE GENITAL SHEDDING OF HIV-1 POSES INFECTION RISK (pp 1564, 1593)
A study in this week's issue of THE LANCET suggests that heterosexual women with HIV-1-including those who have had successful antiretroviral therapy-are at risk of transmitting HIV to their sexual partners and newborn infants as a result of viral shedding in the genital tract. Plasma HIV-1 RNA concentration has been the best predictor for risk of... view more... (2001-11-07)
Model of pre-exposure prophylaxis against HIV forecasts benefits, potential cost-effectiveness
For every two people who begin treatment for HIV infection globally, five others become newly infected. Therefore, preventing new HIV infections is the foremost strategy for ending the HIV/AIDS epidemic. view more (2009-02-10)
HIV Mortality in India Drops with Introduction of Generic Antiretroviral Therapy
The survival rate of HIV-infected patients in India has risen in response to a 20-fold drop in the price of antiretroviral therapy (ART), according to an article in the Nov. 15 issue of Clinical Infectious Diseases, now available online. view more (2005-10-20)
|
|
| Page
2 of
8 |
156 Results |
|
|
|
Sort By:
Page Views | Date |
|
